Borderline ovarian tumours: management in the era of fertility-sparing surgery

6 May 2020

Mattia Maramai, Fabio Barra, Mario Valenzano Menada, Sara Stigliani, Melita Moioli, Sergio Costantini, Simone Ferrero

Borderline ovarian tumours (BOTs) are ovarian neoplasms characterised by epithelial proliferation, variable nuclear atypia and no evidence of destructive stromal invasion. BOTs account for approximately 15% of all epithelial ovarian cancers. Due to the fact that the majority of BOTs occur in women under 40 years of age, their surgical management often has to consider fertility-sparing approaches. The aim of this mini-review is to discuss the state of the art of fertility-sparing surgery for BOTs with a specific focus on the extent of surgery, post-operative management and fertility.

2071-the-global-cancer-crisis-a-review-of-growing-burden-deepening-inequality-and-initiatives-for-prevention-and-early-detection

Review: The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection

Charles M Balch, Ning Liao, Denis S C Lam, Jeffrey N Weitzel, Rui-Hua Xu, Gerhardt Attard, Paul A Bunn, Alexander M M Eggermont, Jie He, Yuko Kitagawa, Soon Thye Lim, Eduardo Cazap, Bernard Esquivel, Xianqun Fan, Louis W C Chow, Edward S F Liu, Hector Martinez Said, John E Niederhuber, Isabel T Rubio, Ashraf Saad Zaghloul, Oscar G Arrieta, Riccardo A Audisio, Geerard L Beets, Felipe J F Coimbra, Jorge E Gallardo, Judy E Garber, Alessandro Gronchi, Volker Heinemann, Allison W Kurian, Miriam Mutebi, Masaki Mori, Funmi I Olopade, Piotr Rutkowski, Mansoor Saleh, William M Sanchez, Raymond Sawaya, John F Thompson, Gerald Tumusiime, Carlos S Vallejos, David C Whiteman, YiLong Wu, King-David T Yawe, Nayef Awad Al Zahrani, Odysseas Zoras, Banu K Arun, Carol J Fabian, Jeffrey E Gershenwald, William J Gradishar, Jin He, V Suzanne Kimberg, Ronald M K Lam, Victor H F Lee, Domenica Lorusso, Tony S K Mok, N D Perrier, Hope S Rugo, Cornelia Ulrich, Chandrakanth Are

3 Feb 2026

https://doi.org/10.3332/ecancer.2026.2071

Abstract | Full Article | PDF

2070-locally-advanced-breast-cancer-is-the-number-of-dissected-nodes-after-neoadjuvant-chemotherapy-important

Review: Locally advanced breast cancer is the number of dissected nodes after neoadjuvant chemotherapy important?

Josepmilly Del Valle Peña Colmenares, Wladimir José Villegas Rodríguez, Osama Bahsas Zaky, Carlos Eduardo Martínez, Douglas José Angulo Herrera

30 Jan 2026

https://doi.org/10.3332/ecancer.2026.2070

Abstract | Full Article | PDF

2066-real-world-evaluation-of-bevacizumab-plus-platinum-and-paclitaxel-for-advanced-cervical-cancer-a-single-arm-study-from-syria

Clinical Study: Real-world evaluation of bevacizumab plus platinum and paclitaxel for advanced cervical cancer: a single-arm study from Syria

Bana Mohamad, Maher Saifo

22 Jan 2026

https://doi.org/10.3332/ecancer.2026.2066

Abstract | Full Article | PDF

2067-a-report-from-the-second-tanzania-liver-cancer-conference-tlcc-2025-leading-the-fight-against-liver-cancer-in-sub-saharan-africa

Conference Report: A report from the Second Tanzania Liver Cancer Conference (TLCC) 2025 – leading the fight against liver cancer in Sub-Saharan Africa

Ally H Mwanga, Jeanine Justiniano, Eric M Mbuguje, Balowa Musa, Deogratius B Mwanakulya, Andrew Swallow, Edith Kimambo, Eva Uiso, Swaleh Pazi, Latifa Rajab, Nashivai E Kivuyo, Larry Akoko, Azza Naif, Advera Ngaiza, Sara Nyagabona, Jerry Ndumbalo, Amos R Mwakigonja, Jim E Littlejohn, Seif Wibonela, Cameron E Gaskill

22 Jan 2026

https://doi.org/10.3332/ecancer.2026.2067

Abstract | Full Article | PDF